Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in JSPR — Jasper Therapeutics, Inc.

CIK 1214717 BOSTON, MA
Back to JSPR Full portfolio

Position in JSPR

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$111,063
-$167,221 QoQ
Shares Held
263,808
-17.0% QoQ
Ownership
0.793%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 44 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in JSPR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. JSPR ranks #438 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in JSPR

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $111,063 263,808
2026-03-31 $278,284 317,677
2025-12-31 $387,697 211,857
2025-09-30 $311,434 130,855
2025-06-30 $727,771 131,130
2025-03-31 $1,133,840 263,684
2024-12-31 $5,509,347 257,687
2024-09-30 $4,841,994 257,416
2024-06-30 $5,896,415 259,754
2024-03-31 $3,757,815 127,991
2023-12-31 $713,632 904,477
2023-09-30 $633,133 904,477
2023-06-30 $1,322,740 965,504
2023-03-31 $1,937,268 1,070,314
2022-12-31 $61,541 127,416
2022-09-30 $100,782 127,734
2022-06-30 $246,526 127,734
2022-03-31 $453,455 127,734
2021-12-31 $918,842 117,050